The pathogenesis, diagnosis and treatment of lupus nephritis.
about
Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.Novel Autoantigens Associated with Lupus Nephritis.Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cells.Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption.CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.Isoflurane attenuates murine lupus nephritis by inhibiting NLRP3 inflammasome activation.CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE.Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: From a Southern Chinese Han PopulationLupus nephritis in children - 10 years' experience.Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.Urinary neutrophil gelatinase-associated lipocalin for diagnosis and estimating activity in lupus nephritis: a meta-analysis.Lupus nephritis: an update.Protein arrays for biomarker discovery in lupus.Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.Amending HIV Drugs: A Novel Small-Molecule Approach To Target Lupus Anti-DNA AntibodiesDevelopment and validation of an impedance biosensor for point-of-care detection of vascular cell adhesion molecule-1 toward lupus diagnostics.Childhood lupus nephritis: 12 years of experience from a developing country's perspective.Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis.Next generation sequencing identifies miRNA-based biomarker panel for lupus nephritis.
P2860
Q30245390-CC6BF542-5DF1-4DAA-9000-8945BF70B605Q35670637-BBC0E274-7C71-49FC-8F13-E1AC43BB4062Q35836741-AB980867-DD1B-4529-9471-40672BF1D669Q36101523-CDDF846B-2435-4296-A175-216A79E773AFQ36166909-19083420-226C-48B3-A5BD-54F41BB0ABD2Q36411613-0CE955D9-2A7D-43B2-9A24-7AD309595245Q37273827-245F3C86-18E7-40A5-9BF2-A8B55DE04EE7Q37322751-96C64D9F-D039-4037-96F3-84BAA4EE4B36Q37399315-2EEC7FE7-8F3C-4E69-BE8E-D6FCDA00A203Q38396871-8C0658F8-9F44-4521-82A5-D7D15CAE7AE7Q38575134-DB0F4904-3336-40B0-8F2E-DBB73F4605F0Q38608138-30116519-71D4-43FA-B44A-9B1B16318D38Q38673773-D66C57AD-5CB6-41E0-BF2A-2581F3BA45F6Q38877052-E2965A2D-0359-4454-940D-8B8DC6293F33Q38990736-BE2FDED7-2CC1-4C83-AF43-BA5015DC94D0Q39100146-5DED6A29-8FA1-4CA4-888A-0A6BA1D5BD58Q39160729-56C281D6-C2EA-46B1-AF4C-7D13E84A48A6Q41406224-3FAA76CB-80C6-4C17-ACF7-DB2341FE9F3FQ41609147-3B259D88-7DE7-4A5D-B15D-9864258296B4Q47164898-F6117C12-B6AC-40D1-989C-56E66F6E103EQ47565445-CAD0FE5B-0CB4-4396-8E53-315EF7329D82Q49486030-EC7455C2-EDFF-44B7-9056-078DD29E240FQ55381725-B26CC27E-4E45-43C1-A618-3AAD8B63C9D2
P2860
The pathogenesis, diagnosis and treatment of lupus nephritis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The pathogenesis, diagnosis and treatment of lupus nephritis.
@ast
The pathogenesis, diagnosis and treatment of lupus nephritis.
@en
type
label
The pathogenesis, diagnosis and treatment of lupus nephritis.
@ast
The pathogenesis, diagnosis and treatment of lupus nephritis.
@en
prefLabel
The pathogenesis, diagnosis and treatment of lupus nephritis.
@ast
The pathogenesis, diagnosis and treatment of lupus nephritis.
@en
P2093
P2860
P1476
The pathogenesis, diagnosis and treatment of lupus nephritis.
@en
P2093
Beatrice Goilav
Chaim Putterman
Noa Schwartz
P2860
P304
P356
10.1097/BOR.0000000000000089
P577
2014-09-01T00:00:00Z